EXEL-0862, a novel tyrosine kinase inhibitor, induces apoptosis in vitro and ex vivo in human mast cells expressing the KIT D816V mutation
Jingxuan Pan, Alfonso Quintás-Cardama, Hagop M. Kantarjian, Cem Akin, Taghi Manshouri, Peter Lamb, Jorge E. Cortes, Ayalew Tefferi, Francis J. Giles, Srdan Verstovsek
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'EXEL-0862, a novel tyrosine kinase inhibitor, induces apoptosis in vitro and ex vivo in human mast cells expressing the KIT D816V mutation'. Together they form a unique fingerprint.